BRÈVE

sur AlzChem Group AG (isin : DE000A0AHT46)

Alzchem Advances Nitroguanidine Production in the U.S.

On November 16, 2026, Alzchem Group AG announced significant strides in its planned nitroguanidine production facility in the U.S. This project, aimed at solidifying its role in the North American defense market, has progressed with the Supervisory Board's approval to procure essential long-lead-time components. This advancement sets the stage for the next phase of project implementation.

The financial backing comes from the U.S. Department of Defense, which has committed to covering the production facility's costs. The parties are finalizing contractual details as the project moves along. The facility, located in Bushy Park, South Carolina, is expected to be operational by 2029. Alzchem will source precursors from Germany, strengthening both U.S. supply chains and German value creation.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AlzChem Group AG